Physician profile
Liang Zhou
NPI 1639581085
$21,768.77
in general payments reported to CMS, 2019-2025
14 companies · $1,233 in 2025
The $1,233 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2021: $62.96 · 2022: $4,493 · 2023: $2,494 · 2024: $2,697 · 2025: $1,233.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,361 · Food and Beverage: $2,063.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,361.06 |
| Food and Beverage | $2,063.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $10,482.45 | 2019-2025 | |
| Stryker Corporation | $5,630.06 | 2019-2025 | Iconix, Inspace, Salvation |
| Elevate Surgical Co | $2,424.13 | 2022 | |
| Linvatec Corporation | $2,113.46 | 2023 | Biobrace 23mm, Allograft Tissue, Livatec Knee Preservation System |
| Supreme Orthopedic Systems, LLC | $350.91 | 2024-2025 | |
| Zimmer Biomet Holdings, INC. | $275.65 | 2019 | |
| Heron Therapeutics, INC. | $110.00 | 2022 | |
| Bioventus LLC | $104.38 | 2022-2023 | Durolane |
| Exactech, INC. | $79.07 | 2019 | |
| Janssen Pharmaceuticals, INC | $68.39 | 2025 | Spravato |
| Acumed LLC | $66.59 | 2025 | Acumed |
| Wright Medical Technology, INC. | $23.76 | 2019 | |
| Vericel Corporation | $20.33 | 2024 | Maci |
| Impactortho, INC. | $19.59 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Liang Zhou listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.